Daily non-political popular news in brief.
New research may overturn conventional wisdom on drug-resistant tuberculosis
02-20-2007 · EurekAlert!A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance. If confirmed in future studies the research, in the March 15 issue of the Journal of Infectious Diseases, may drive a major shift in strategy for controlling TB.
Read more »
Keywords: research, overturn, conventional, wisdom, drug-resistant, tuberculosis, drug, resistant, tuberculosi
« Previous | Next »
Similar news on "New research may overturn conventional wisdom on drug-resistant tuberculosis":
- NIAID releases MDR/XDR Tuberculosis research agenda
06-06-2007 · EurekAlert!
NIAID today released its NIAID Research Agenda for Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis (TB). While focusing on MDR/XDR TB, many of the research priorities identified in this document also relate to drug-sensitive tuberculosis. The research priorities identified in the agenda build on a foundation of ongoing NIAID-supported TB research, which currently comprises more than 300 research projects worldwide.
Similar news · Read more »
- Quality not quantity important for immune response to HIV
12-17-2006 · EurekAlert!
When it comes to an immune response against HIV, research funded by the Wellcome Trust in the UK and the National Institutes of Health in the US has found that bigger is not necessarily better, contrary to conventional medical wisdom. The research may have a profound impact on the development of a vaccine against the disease.
Similar news · Read more »
- Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
01-22-2007 · EurekAlert!
Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
Similar news · Read more »
- Restoring tamoxifen sensitivity in resistant breast cancer cells
12-20-2006 · EurekAlert!
The widely used breast cancer drug tamoxifen (Nolvadex), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute, part of the National Institutes of Health, and their partners.
Similar news · Read more »
- English-only policies may not promote success for Spanish-speaking pre-schoolers
03-22-2007 · EurekAlert!
Contrary to conventional wisdom, English-only pre-kindergarten classrooms may not help native Spanish-speaking children become better prepared for school. According to research by FPG Child Development Institute at the University of North Carolina at Chapel Hill, Spanish-speaking children had better social skills when their teachers spoke some Spanish.
Similar news · Read more »
- Extensively drug-resistant tuberculosis is emerging threat
10-27-2006 · EurekAlert!
Strains of tuberculosis (TB) that are resistant to both first-line and second-line drugs could threaten the success of not only tuberculosis programs, but also HIV treatment programs worldwide, according to an article published online this week in the Lancet.
Similar news · Read more »
- Drug resistance in an influenza pandemic
01-22-2007 · EurekAlert!
Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries. However, it is known that influenza viruses can develop resistance to these drugs. New research suggests that wide-spread use of antiviral drugs during a pandemic carries a substantial risk of resistance emerging and resistant influenza strains causing illness in a substantial number of people.
Similar news · Read more »
- Scripps research team blocks bacterial communication system to prevent deadly staph infections
10-30-2007 · EurekAlert!
In hopes of combating the growing scourge of antibiotic-resistant bacteria, in particular drug-resistant staph bacteria, a team of scientists from The Scripps Research Institute has designed a new type of vaccine that could one day be used in humans to block the onset of infection.
Similar news · Read more »
- Their immune cells, fighting your cancer
09-19-2007 · EurekAlert!
Immune cells from "cancer-resistant" people could be used to help other people fight cancer. A scientist in the US has discovered that immune cells called granulocytes can kill cancer, and their effectiveness varies from person to person. The research team have now received permission from the US Food and Drug Administration to screen people for their ability to ward off cancer. Immune cells with the best cancer-fighting ability will be transferred to cancer patients, after being matched for blood type.
Similar news · Read more »
- XDR TB in South Africa traced to lack of drug susceptibility testing
10-22-2007 · EurekAlert!
In South Africa, the 2001 implementation of the World Health Organization's antituberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis. In a new study published in the Dec. 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.
Similar news · Read more »